34 results on '"Nabbout, R"'
Search Results
2. Electro-clinical features in epileptic children with chromosome 15q duplication syndrome
3. Behavioral and physiological analysis in a kcnb1 knock-out zebrafish model of epilepsy and neurodevelopmental disorders
4. Physician and patient satisfaction with the switch to remote outpatient encounters in epilepsy clinics during the Covid-19 pandemic.
5. Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy
6. Infantile spasms in Down syndrome—effects of delayed anticonvulsive treatment
7. P.0663 Zebrafish model : study of KCNB1 in developmental and epileptic encephalopathies
8. The brave new world of genetics in epilepsy
9. Updating Tuberous sclerosis complex care for pediatric neurologists.
10. Unusual consequences of status epilepticus in Dravet syndrome.
11. Long term response to steroid therapy in Rasmussen encephalitis.
12. Interhemispheric coherence of EEG rhythms in children: Maturation and differentiation in corpus callosum dysgenesis.
13. Diagnostic evaluation and management of seizures and status epilepticus in children with known epilepsy or new-onset seizures: A retrospective and comparative analysis.
14. Antiepileptic treatment in Dravet syndrome: An additional complexity for the families.
15. Efficacy of ketogenic diet in resistant myoclono-astatic epilepsy: A french multicenter retrospective study.
16. Sustained reduction in seizure frequency with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC) in children under 6 years of age: Results from the phase 3 EXIST-3 extension phase.
17. Off-label use and manipulations of AEDs in pediatric: The experience of a tertiary epilepsy centre.
18. Prospective neuropsychiatric follow up in TSC infants from diagnosis to 12 months.
19. RUFIPRAT: A retrospective study on the everyday clinical use of Rufinamide in children with refractory epilepsy.
20. Long term outcome of patients with Epilepsy with migrating focal seizure in infancy (EMFSI) due to KCNT1 mutation.
21. PP01.9 – 2684: Late cognitive delay in Dravet syndrome, after the age of 6 years: Report of four cases.
22. PP01.3 – 2692: Child epilepsy with PCDH-19 mutation: Cognitive and behavioral data.
23. P56 – 3039: Off label and unlicensed use of AEDs in pediatric population: A retrospective study.
24. Video-EEG study of early onset epileptic encephalopathy with suppression bursts.
25. P241 – 2093 Tuberous sclerosis complex: multiple tubers with no functional impact – a case report.
26. P17 – 2103 Early epileptic encephalopathies associated with STXBP1 mutations: three new patients with different electroclinical profile evoluting to infantile spasms.
27. PP2.2 – 2026 Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy.
28. O7 – 2139 Epilepsy and PCDH19 mutation: electrophysiological features.
29. Brain functional imaging SPECT in agyria-pachygyria
30. PIH4 NUMBER NEEDED TO TREAT (NNT) WITH FENFLURAMINE TO ACHIEVE A CLINICALLY MEANINGFUL REDUCTION IN CONVULSIVE SEIZURE FREQUENCY IN PATIENTS WITH DRAVET SYNDROME: HEALTH ECONOMIC IMPLICATIONS.
31. OC16: Electro-clinical features in epileptic children with chromosome 15qduplication syndrome.
32. Épilepsies néonatales et erreurs innées du métabolisme
33. A novel mutation in STXBP1 causing epileptic encephalopathy (late onset infantile spasms) with partial respiratory chain complex IV deficiency.
34. Éverolimus chez des patients atteints d’astrocytomes sous épendymaires à cellules géantes (SEGA) associés à une sclérose tubéreuse de Bourneville (STB) en France : résultats préliminaires. Étude européenne Effects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.